OPKO Health, Inc.OPKNASDAQ
LOADING
|||
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q3 2025 | -0.87% |
| Q2 2025 | -1.62% |
| Q1 2025 | 1.37% |
| Q4 2024 | 5.75% |
| Q3 2024 | 19.47% |
| Q2 2024 | 9.78% |
| Q1 2024 | 13.08% |
| Q4 2023 | -0.18% |
| Q3 2023 | 7.03% |
| Q2 2023 | -44.31% |
| Q1 2023 | 66.97% |
| Q4 2022 | 3.92% |
| Q3 2022 | 8.91% |
| Q2 2022 | -5.78% |
| Q1 2022 | -12.83% |
| Q4 2021 | 14.75% |
| Q3 2021 | 0.46% |
| Q2 2021 | -5.66% |
| Q1 2021 | 10.37% |
| Q4 2020 | -5.37% |
| Q3 2020 | 5.03% |
| Q2 2020 | -19.08% |
| Q1 2020 | -5.55% |
| Q4 2019 | -23.25% |
| Q3 2019 | 6.12% |
| Q2 2019 | -23.44% |
| Q1 2019 | 10.95% |
| Q4 2018 | 7.42% |
| Q3 2018 | 6.12% |
| Q2 2018 | -11.21% |
| Q1 2018 | -3.80% |
| Q4 2017 | 5.79% |
| Q3 2017 | -2.41% |
| Q2 2017 | 24.74% |
| Q1 2017 | -3.78% |
| Q4 2016 | 10.30% |
| Q3 2016 | -21.84% |
| Q2 2016 | 15.07% |
| Q1 2016 | 9.20% |
| Q4 2015 | 34.54% |